|
Volumn 85, Issue 11, 2008, Pages 1670-1671
|
Combined pancreatic islet-lung transplantation with islet percutaneous portal embolization in cystic fibrosis
c
HÔPITAL CIVIL
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
AZATHIOPRINE;
C PEPTIDE;
CORTICOSTEROID;
CYCLOSPORIN;
HEMOGLOBIN A1C;
INSULIN;
ABDOMINAL BLEEDING;
ACUTE GRAFT REJECTION;
ADULT;
ALLOTRANSPLANTATION;
ARTIFICIAL EMBOLISM;
CASE REPORT;
CATHETERIZATION;
CELL CULTURE;
CELL VIABILITY;
CHRONIC RESPIRATORY FAILURE;
COMPARATIVE STUDY;
CYSTIC FIBROSIS;
DIABETES CONTROL;
EXTUBATION;
GENE MUTATION;
HOSPITAL ADMISSION;
HUMAN;
HYPOGLYCEMIA;
INFECTION;
INSULIN DEPENDENT DIABETES MELLITUS;
KIDNEY FAILURE;
LETTER;
LUNG DISEASE;
LUNG FUNCTION;
LUNG TRANSPLANTATION;
MALE;
MALNUTRITION;
METABOLISM;
MORBIDITY;
PANCREAS INSUFFICIENCY;
PANCREAS ISLET;
PANCREAS TRANSPLANTATION;
PARENTERAL NUTRITION;
POSTOPERATIVE CARE;
PREVALENCE;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
SURGICAL APPROACH;
TREATMENT DURATION;
VEIN THROMBOSIS;
FOLLOW UP;
METHODOLOGY;
PANCREAS ISLET TRANSPLANTATION;
PORTAL VEIN;
ADULT;
CYSTIC FIBROSIS;
EMBOLIZATION, THERAPEUTIC;
FOLLOW-UP STUDIES;
HUMANS;
ISLETS OF LANGERHANS TRANSPLANTATION;
LUNG TRANSPLANTATION;
MALE;
PORTAL VEIN;
|
EID: 47049088383
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/TP.0b013e3181722fde Document Type: Letter |
Times cited : (14)
|
References (5)
|